Cargando…
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751847/ https://www.ncbi.nlm.nih.gov/pubmed/33347498 http://dx.doi.org/10.1371/journal.ppat.1009167 |
| _version_ | 1783625737677307904 |
|---|---|
| author | Caduff, Nicole McHugh, Donal Murer, Anita Rämer, Patrick Raykova, Ana Landtwing, Vanessa Rieble, Lisa Keller, Christian W. Prummer, Michael Hoffmann, Laurent Lam, Janice K. P. Chiang, Alan K. S. Raulf, Friedrich Azzi, Tarik Berger, Christoph Rubic-Schneider, Tina Traggiai, Elisabetta Lünemann, Jan D. Kammüller, Michael Münz, Christian |
| author_facet | Caduff, Nicole McHugh, Donal Murer, Anita Rämer, Patrick Raykova, Ana Landtwing, Vanessa Rieble, Lisa Keller, Christian W. Prummer, Michael Hoffmann, Laurent Lam, Janice K. P. Chiang, Alan K. S. Raulf, Friedrich Azzi, Tarik Berger, Christoph Rubic-Schneider, Tina Traggiai, Elisabetta Lünemann, Jan D. Kammüller, Michael Münz, Christian |
| author_sort | Caduff, Nicole |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7751847 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77518472021-01-05 Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice Caduff, Nicole McHugh, Donal Murer, Anita Rämer, Patrick Raykova, Ana Landtwing, Vanessa Rieble, Lisa Keller, Christian W. Prummer, Michael Hoffmann, Laurent Lam, Janice K. P. Chiang, Alan K. S. Raulf, Friedrich Azzi, Tarik Berger, Christoph Rubic-Schneider, Tina Traggiai, Elisabetta Lünemann, Jan D. Kammüller, Michael Münz, Christian PLoS Pathog Correction Public Library of Science 2020-12-21 /pmc/articles/PMC7751847/ /pubmed/33347498 http://dx.doi.org/10.1371/journal.ppat.1009167 Text en © 2020 Caduff et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Caduff, Nicole McHugh, Donal Murer, Anita Rämer, Patrick Raykova, Ana Landtwing, Vanessa Rieble, Lisa Keller, Christian W. Prummer, Michael Hoffmann, Laurent Lam, Janice K. P. Chiang, Alan K. S. Raulf, Friedrich Azzi, Tarik Berger, Christoph Rubic-Schneider, Tina Traggiai, Elisabetta Lünemann, Jan D. Kammüller, Michael Münz, Christian Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice |
| title | Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice |
| title_full | Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice |
| title_fullStr | Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice |
| title_full_unstemmed | Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice |
| title_short | Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice |
| title_sort | correction: immunosuppressive fk506 treatment leads to more frequent ebv-associated lymphoproliferative disease in humanized mice |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751847/ https://www.ncbi.nlm.nih.gov/pubmed/33347498 http://dx.doi.org/10.1371/journal.ppat.1009167 |
| work_keys_str_mv | AT caduffnicole correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT mchughdonal correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT mureranita correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT ramerpatrick correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT raykovaana correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT landtwingvanessa correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT rieblelisa correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT kellerchristianw correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT prummermichael correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT hoffmannlaurent correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT lamjanicekp correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT chiangalanks correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT raulffriedrich correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT azzitarik correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT bergerchristoph correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT rubicschneidertina correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT traggiaielisabetta correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT lunemannjand correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT kammullermichael correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice AT munzchristian correctionimmunosuppressivefk506treatmentleadstomorefrequentebvassociatedlymphoproliferativediseaseinhumanizedmice |